Clinical Trial Update: Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of chemotherapy and peripheral stem cell transplantation followed by trastuzumab for metastatic breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: WITHDRAWN